Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington’s Disease and Human Blood Plasma

Open access
Ananbeh, Hanadi, Novak, Jaromir, Juhas, Stefan, Juhasova, Jana, Klempir, Jiri, Doleckova, Kristyna, Rysankova, Irena, Turnovcova, Karolina, Hanus, Jaroslav, Hansikova, Hana, Vodicka, Petr, Kupcova Skalnikova, Helena · 2022 · International Journal of Molecular Sciences

Abstract

(1) Background: Huntington’s disease (HD) is rare incurable hereditary neurodegenerative disorder caused by CAG repeat expansion in the gene coding for the protein huntingtin (HTT). Mutated huntingtin (mHTT) undergoes fragmentation and accumulation, affecting cellular functions and leading to neuronal cell death. Porcine models of HD are used in preclinical testing of currently emerging disease modifying therapies. Such therapies are aimed at reducing mHTT expression, postpone the disease onset, slow down the progression, and point out the need of biomarkers to monitor disease development and therapy efficacy. Recently, extracellular vesicles (EVs), particularly exosomes, gained attention as possible carriers of disease biomarkers. We aimed to characterize HTT and mHTT forms/fragments in blood plasma derived EVs in transgenic (TgHD) and knock-in (KI-HD) porcine models, as well as in HD patients’ plasma. (2) Methods: Small EVs were isolated by ultracentrifugation and HTT forms were visualized by western blotting. (3) Results: The full length 360 kDa HTT co-isolated with EVs from both the pig model and HD patient plasma. In addition, a ~70 kDa mutant HTT fragment was specific for TgHD pigs. Elevated total huntingtin levels in EVs from plasma of HD groups compared to controls were observed in both pig models and HD patients, however only in TgHD were they significant (p = 0.02). (4) Conclusions: Our study represents a valuable initial step towards the characterization of EV content in the search for HD biomarkers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms23105598

Cites

Statistics

Figures

Figure 1 Experimental scheme.
Figure 1 Experimental scheme.CC BY · PubMed Central
Figure 2 Characterization of the morphology and size of extracellular vesicles. (A) TEM confirmed presence of spherical vesicles with diameter smaller than 200 nm in the ultracentrifugation pellets from porcine and human plasma (representative image from 20 samples analyzed by TEM is shown). Magnification 100,000×. (B) Characterization of particle size by NTA. Representative result from 46 samples analyzed by NTA is shown. Error bars (red) indicate ±1 standard error of the mean (see Table S1 for detailed data). (C) Nanoscale flow cytometry with fluorescent CFSE labelling was used to assess size of particles of biological origin in ultracentrifugation pellets from plasma. The most frequent particle size category was 110 nm. Dots represent individual samples, bars represent mean of % of total CFSE+ particles in individual genotype and size groups, error bars show standard error of the mean (see Table S1 for detailed data).
Figure 2 Characterization of the morphology and size of extracellular vesicles. (A) TEM confirmed presence of spherical vesicles with diameter smaller than 200 nm in the ultracentrifugation pellets from porcine and human plasma (representative image from 20 samples analyzed by TEM is shown). Magnification 100,000×. (B) Characterization of particle size by NTA. Representative result from 46 samples analyzed by NTA is shown. Error bars (red) indicate ±1 standard error of the mean (see Table S1 for detailed data). (C) Nanoscale flow cytometry with fluorescent CFSE labelling was used to assess size of particles of biological origin in ultracentrifugation pellets from plasma. The most frequent particle size category was 110 nm. Dots represent individual samples, bars represent mean of % of total CFSE+ particles in individual genotype and size groups, error bars show standard error of the mean (see Table S1 for detailed data).CC BY · PubMed Central
Figure 3 Huntingtin and exosome marker detection in 100,000× g centrifugation pellets containing extracellular vesicles, isolated from blood plasma of the transgenic Huntington´s disease pig model. (A) anti-N-terminal HTT antibody (EPR5526) was used to detect total HTT levels in plasma, 10,000× g pellets and 100,000× g pellets. Wild-type pig brain homogenate was used as positive control. Endogenous full length ~360 kDa HTT was detectable in 10,000× g and 100,000× g pellets from plasma of both wild type (wt) and transgenic (TgHD) pigs (arrow E). In addition, the ~110 kDa human HTT transgene (arrow T) and a ~70 kDa fragment (arrow F) were detectable in TgHD pig 100,000× g pellets. (B) A polyQ-specific antibody (MW1) provided the same ~110 and ~70 kDa band pattern in TgHD pig 100,000× g pellets as EPR5526, thus confirming the presence of mutant HTT (arrows). Additional polyQ-containing protein bands were detected in 100,000× g pellets (asterisks). (C) Expression of exosome markers Alix, TSG101 and CD9 were abundant in 100,000× g pellets containing extracellular vesicles, in contrast to 10,000× g pellets and original plasma (sample IDs are identical as in panel (A)).
Figure 3 Huntingtin and exosome marker detection in 100,000× g centrifugation pellets containing extracellular vesicles, isolated from blood plasma of the transgenic Huntington´s disease pig model. (A) anti-N-terminal HTT antibody (EPR5526) was used to detect total HTT levels in plasma, 10,000× g pellets and 100,000× g pellets. Wild-type pig brain homogenate was used as positive control. Endogenous full length ~360 kDa HTT was detectable in 10,000× g and 100,000× g pellets from plasma of both wild type (wt) and transgenic (TgHD) pigs (arrow E). In addition, the ~110 kDa human HTT transgene (arrow T) and a ~70 kDa fragment (arrow F) were detectable in TgHD pig 100,000× g pellets. (B) A polyQ-specific antibody (MW1) provided the same ~110 and ~70 kDa band pattern in TgHD pig 100,000× g pellets as EPR5526, thus confirming the presence of mutant HTT (arrows). Additional polyQ-containing protein bands were detected in 100,000× g pellets (asterisks). (C) Expression of exosome markers Alix, TSG101 and CD9 were abundant in 100,000× g pellets containing extracellular vesicles, in contrast to 10,000× g pellets and original plasma (sample IDs are identical as in panel (A)).CC BY · PubMed Central
Figure 4 Huntingtin and exosome marker detection in fractions from density gradient ultracentrifugation. The 100,000× g pellet from the T131 transgenic pig plasma (sample labeled “+”) was overlaid by 40% to 5% OptiPrep and separated by gradient ultracentrifugation. Seventeen fractions (1 mL each) were collected from top of the tube. The collected fractions were subjected to SDS-PAGE and western blotting to detect total huntingtin (A), mutant huntingtin (B) and exosome markers Alix, TSG101 and CD9 (C). Huntingtin appeared in fraction 13 with density 1.111–1.134 g/cm3 corresponding to exosomes. Fraction 13 was also positive to exosome markers. Arrows indicate ~360 kDa endogenous huntingtin (E), ~110 kDa huntingtin transgene (T) and ~70 kDa huntingtin fragment (F). The extracellular vesicles in fraction 13 macroscopically appeared as an opalescent band in the ultracentrifugation tube (arrow in panel (D). Representative results from 5 samples fractionated by gradient ultracentrifugation are shown (see Figures S8–S12 for full data).
Figure 4 Huntingtin and exosome marker detection in fractions from density gradient ultracentrifugation. The 100,000× g pellet from the T131 transgenic pig plasma (sample labeled “+”) was overlaid by 40% to 5% OptiPrep and separated by gradient ultracentrifugation. Seventeen fractions (1 mL each) were collected from top of the tube. The collected fractions were subjected to SDS-PAGE and western blotting to detect total huntingtin (A), mutant huntingtin (B) and exosome markers Alix, TSG101 and CD9 (C). Huntingtin appeared in fraction 13 with density 1.111–1.134 g/cm3 corresponding to exosomes. Fraction 13 was also positive to exosome markers. Arrows indicate ~360 kDa endogenous huntingtin (E), ~110 kDa huntingtin transgene (T) and ~70 kDa huntingtin fragment (F). The extracellular vesicles in fraction 13 macroscopically appeared as an opalescent band in the ultracentrifugation tube (arrow in panel (D). Representative results from 5 samples fractionated by gradient ultracentrifugation are shown (see Figures S8–S12 for full data).CC BY · PubMed Central
Figure 5 Normalized intensity of total huntingtin in extracellular vesicles isolated from blood plasma of TgHD and KI-HD pig models and human plasma. EVs were isolated by ultracentrifugation and HTT forms were detected by western blot using anti-N-terminal HTT antibody recognizing both normal and mutant HTT. HTT band intensities were quantified by ImageLab software and normalized to CD9 levels to minimize variability in EV loading amount. Significantly higher total HTT content was found in vesicles from TgHD pigs compared to WT control pigs (A), while in KI-HD (B) and HD patients (C) the increase in total HTT in EVs compared to controls was not significant. The dots represent individual samples, bars show mean of the groups, and error bars indicate standard error of the mean. Statistical analysis using three-way ANOVA with genotype and age and sex as factors, followed by the post-hoc Tukey HSD test was performed for pig samples. T-test was used to compare HTT intensity between HD patient and control groups.
Figure 5 Normalized intensity of total huntingtin in extracellular vesicles isolated from blood plasma of TgHD and KI-HD pig models and human plasma. EVs were isolated by ultracentrifugation and HTT forms were detected by western blot using anti-N-terminal HTT antibody recognizing both normal and mutant HTT. HTT band intensities were quantified by ImageLab software and normalized to CD9 levels to minimize variability in EV loading amount. Significantly higher total HTT content was found in vesicles from TgHD pigs compared to WT control pigs (A), while in KI-HD (B) and HD patients (C) the increase in total HTT in EVs compared to controls was not significant. The dots represent individual samples, bars show mean of the groups, and error bars indicate standard error of the mean. Statistical analysis using three-way ANOVA with genotype and age and sex as factors, followed by the post-hoc Tukey HSD test was performed for pig samples. T-test was used to compare HTT intensity between HD patient and control groups.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 108 · Cited by 46

Metadata

Authors
Ananbeh, H., Novak, J., Juhas, S., Juhasova, J., Klempir, J., Doleckova, K., Rysankova, I., Turnovcova, K., Hanus, J., Hansikova, H., Vodicka, P., & Kupcova Skalnikova, H.
Affiliations
  • Czech Academy of Sciences (CZ)
  • Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, Rumburska 89, 27721 Libechov, Czech Republic
  • Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, Katerinska 30, 12821 Prague, Czech Republic
  • Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, Czech Republic
  • Department of Chemical Engineering, University of Chemistry and Technology, Technicka 3, 16628 Prague, Czech Republic
  • Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 2, 12808 Prague, Czech Republic
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-05-17
Volume
23
Issue
10
Pages
5598
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4280636734
Cited by
46
References
108
Citations by year
2026: 9 · 2025: 12 · 2024: 12 · 2023: 8 · 2022: 5
FWCI
4.08
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Czech Science Foundation (19-01747S, MZ-ČR RVO-VFN 00064165, GIP 22-SL-05-212, NU20-04-00136, RVO:67985904, 739510)
  • Charles University: Cooperatio Program in Neuroscience (19-01747S, MZ-ČR RVO-VFN 00064165, GIP 22-SL-05-212, NU20-04-00136, RVO:67985904, 739510)
  • General University Hospital in Prague (19-01747S, MZ-ČR RVO-VFN 00064165, GIP 22-SL-05-212, NU20-04-00136, RVO:67985904, 739510)
  • Czech health research council of the Ministry of Health of the Czech Republic (19-01747S, MZ-ČR RVO-VFN 00064165, GIP 22-SL-05-212, NU20-04-00136, RVO:67985904, 739510)
  • European Reference Network for Rare Neurological Diseases (19-01747S, MZ-ČR RVO-VFN 00064165, GIP 22-SL-05-212, NU20-04-00136, RVO:67985904, 739510)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
Keywords
Huntington's disease, huntingtin, mutant huntingtin, extracellular vesicles, small extracellular vesicles, exosomes, blood plasma, porcine model, transgenic pigs, disease biomarkers, CAG repeat expansion, disease-modifying therapy
MeSH terms
Extracellular Vesicles, Animals, Humans, Huntington Disease, Nerve Tissue Proteins, Plasma, Swine, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington’s Disease and Human Blood Plasma. https://app.cochat.ai/papers/10.3390/ijms23105598
The paper
Ananbeh, H., Novak, J., Juhas, S., Juhasova, J., Klempir, J., Doleckova, K., Rysankova, I., Turnovcova, K., Hanus, J., Hansikova, H., Vodicka, P., & Kupcova Skalnikova, H. (2022). Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington’s Disease and Human Blood Plasma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms23105598

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.